ask="0.550"
ask_size="10000"
average_daily_volume="3029840"
bid="0.480"
bid_size="21600"
book_value="0.168"
change="-0.022"
change_from_200_day_moving_average="0.159"
change_from_50_day_moving_average="0.168"
change_from_52_week_high="-0.162"
change_From_52_week_low="0.226"
change_in_percent="-4.151%"
close="0.508"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.204"
ebitda="-41.64M"
eps_estimate_current_year="-0.130"
eps_estimate_next_quarter="-0.030"
eps_estimate_next_year="-0.110"
ex_dividend_date="N/A"
float_shares="229462000"
high="0.538"
high_52_weeks="0.670"
last_trade_date="2/23/2017"
last_trade_price="0.508"
last_trade_size="14380"
last_trade_time="4:00pm"
low="0.485"
low_52_weeks="0.282"
market_capitalization="130.63M"
moving_average_200_day="0.349"
moving_average_50_day="0.340"
name="Peregrine Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="1.250"
open="0.538"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="+45.353%"
percent_change_from_50_day_moving_average="+49.283%"
percent_change_from_52_week_high="-24.179%"
percent_change_from_52_week_low="+80.142%"
previous_close="0.530"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.155"
price_per_sales="2.502"
revenue="54.47M"
shares_outstanding="257141000"
short_ratio="0.620"
stock_exchange="NCM"
symbol="PPHM"
volume="4015356"
weeks_range_52="0.282 - 0.670"
